Home NDC 71860-304 ZANVASTRO
Product NDC 71860-304
11-digit product format 718600304
Labeler code 71860
Product ID 71860-304_5b752db5-061f-8804-e063-6394a90aa4af
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name zilganersen
Dosage form KIT
Labeler Ionis Pharmaceuticals Inc.
Application NDA220210
Marketing category NDA
Marketing start 2026-09-03
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N220210-001 ZANVASTRO ZILGANERSEN SODIUM EQ 56MG BASE/2.8ML (EQ 20MG BASE/ML) SOLUTION / INTRATHECAL RLD, RS 2026-09-03
Orange Book patents# Current patent rows page 1 of 1 · 1 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N220210-001 11786546 2041-05-20 U-4601 Drug substance, Drug product 2026-09-22
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-11-14 07:37:17 2026-10 N220210-001 ZANVASTRO EQ 56MG BASE/2.8ML (EQ 20MG BASE/ML) SOLUTION / INTRATHECAL RLD, RS 2026-09-03 d4dbc9d85df4…2026-10-15 13:18:30 2026-09 N220210-001 ZANVASTRO EQ 56MG BASE/2.8ML (EQ 20MG BASE/ML) SOLUTION / INTRATHECAL RLD, RS 2026-09-03 c2088c7a36db…
Observed Orange Book patent history# Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-11-14 07:37:17 2026-10 N220210-001 11786546 2041-05-20 U-4601 Drug substance, Drug product 2026-09-22 d4dbc9d85df4…2026-10-15 13:18:30 2026-09 N220210-001 11786546 2041-05-20 U-4601 Drug substance, Drug product 2026-09-22 c2088c7a36db…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base ZANVASTRO
Listing expiration 2027-12-31 Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 2753034 Internal RxNorm lookup 2753040 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Sample Exclude flag Status 71860-304-01 71860030401 1 KIT in 1 CARTON (71860-304-01) * 21 mL in 1 VIAL, SINGLE-DOSE (71860-200-01) * 2.8 mL in 1 VIAL, SINGLE-DOSE (71860-104-01) 1 kit 2026-09-03 No No Current